Literature DB >> 28476578

Canagliflozin as a replacement therapy for patients with type 2 diabetes not responding to GLP-1 receptor agonists.

M D Garcia de Lucas1, J Olalla Sierra2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28476578     DOI： 10.1016/j.diabet.2017.03.007

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN： 1262-3636            Impact factor:   6.041


× No keyword cloud information.
  1 in total

Review 1.  The Place of Sulfonylureas in the Evolving Landscape of Combination Therapy.

Authors:  Miao Yu
Journal:  Diabetes Ther       Date:  2020-04-22       Impact factor: 2.945
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.